Walleye Capital’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$117K Buy
+17,409
New +$117K ﹤0.01% 1517
2024
Q3
Sell
-13,323
Closed -$190K 2875
2024
Q2
$190K Buy
+13,323
New +$190K ﹤0.01% 1880
2022
Q2
Sell
-44,652
Closed -$419K 2666
2022
Q1
$419K Buy
+44,652
New +$419K 0.01% 1069